In trabecular meshwork cells, mapracorat behaved as a partial agonist in contrast to traditional glucocorticoids, in increasing myocilin, a protein thought to be involved in steroid-induced glaucoma [25]. The gene discussed is MYOC; the disease is glaucoma.